Approvals/PPB/SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (50 MICROGRAMS/50 MICROGRAMS)/ML

Approved

STANDARD

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (50 MICROGRAMS/50 MICROGRAMS)/ML

MODERNA HONG KONG LIMITED🇰🇪 Pharmacy and Poisons Board

Approval Date: Jun 21, 2024
Approval ID: 3ceeb9bdc5997d0b
Company: MODERNA HONG KONG LIMITED
Type: Standard

Approval Details

Approval Id: 3ceeb9bdc5997d0b
Product Name: SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (50 MICROGRAMS/50 MICROGRAMS)/ML
Drug Hk Name: SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (50 MICROGRAMS/50 MICROGRAMS)/ML
Registration Code: HK-67830
Company Name: MODERNA HONG KONG LIMITED
Company Detail Path: /organization/0c2a778b3c2bf636/moderna-hong-kong-limited
Registration Category: Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement: Prescription only Medicines
Registration Date: 2023-05-04
Company Address: 11/F, ONE PACIFIC PLACE, 88, QUEENSWAY, HONG KONG

Active Ingredients

Approved

Quick Info

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

3ceeb9bdc5997d0b

Type

Standard

Back to PPB Approvals